RGD-Functionalization of poly(2-oxazoline)-based networks for enhanced adhesion to cancer cells

Polymers

Volumn 6, Issue 1, 2014, Pages 264-279

  Schenk, Verena ^a,b   Rossegger, Elisabeth ^a,b   Ebner, Clemens ^a   Bangerl, Florian ^b   Reichmann, Klaus ^b   Hoffmann, Björn ^c   Höpfner, Michael ^c   Wiesbrock, Frank ^a  

^a POLYMER COMPETENCE CENTER LEOBEN GMBH   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer cell recognition; Crosslinked polymer networks; Poly(2 oxazoline)s; RGD interaction with integrins

Indexed keywords

AMINO ACIDS; ENDOTHELIAL CELLS; GELS;

2-ETHYL-2-OXAZOLINE; ARGININE-GLYCINE-ASPARTIC ACIDS; CANCER CELLS; CROSSLINKED POLYMER NETWORKS; FLUORESCEIN ISOTHIOCYANATE; INTEGRINS; POLY(2-OXAZOLINE)S; SURFACE FUNCTIONALIZATION;

NITROGEN COMPOUNDS;

EID: 84894101829     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym6020264     Document Type: Article

References (43)

1. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 2001, 53, 321-339.
2. Knop, K; Hoogenboom, R.; Fischer, D.; Schubert, U.S. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 2010, 49, 6288-6308.
3. Puskas, J.E.; Chen, Y. Biomedical application of commercial polymers and novel polyisobutylene-based thermoplastic elastomers for soft tissue replacement. Biomacromolecules 2004, 5, 1141-1154.
4. Lee, K.Y.; Mooney, D.J. Hydrogels for tissue engineering. Chem. Rev. 2001, 101, 1869-1880.
5. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 2003, 42, 4640-4643.
6. Ulbrich, K.; Subr, V.; Podperova, P.; Buresova, M. Synthesis of novel hydrolytically degradable hydrogels for controlled drug release. J. Control. Release 1995, 34, 155-165.
7. Kelly, A.M.; Wiesbrock, F. Strategies for the synthesis of poly(2-oxazoline)-based hydrogels. Macromol. Rapid Commun. 2012, 33, 1632-1647.
8. Hoogenboom, R.; Schlaad, H. Bioinspired poly(2-oxazoline)s. Polymers 2011, 3, 467-488.
9. Farrugia, B.L.; Kempe, K.; Schubert, U.S.; Hoogenboom, R.; Dargaville, T.R. Poly(2-oxazoline) hydrogels for controlled fibroblast attachment. Biomacromolecules 2013, 14, 2724-2732.
10. Deng, X.; Eyster, T.W.; Elkasabi, Y.; Lahann, J. Bio-orthogonal polymer coatings for co-presentation of biomolecules. Macromol. Rapid Commun. 2012, 33, 640-645.
11. Paterson, S.M.; Shadforth, A.M.A.; Shaw, J.A.; Brown, D.H.; Chirila, T.V.; Baker, M.V. Improving the cellular invasion into PHEMA sponges by incorporation of the RGD peptide ligand: The use of copolymerization as a means to functionalize PHEMA. Mater. Sci. Eng. C Biol. Sci. 2013, 33, 4917-4922.
12. Jabbari, E.; He, X.; Valarmathi, M.T.; Sarvestani, A.S.; Xu, W.J. Material properties and bone marrow stromal cells response to in situ crosslinkable RGD-functionalized lactide-co-glycolide scaffolds. Biomed. Mater. Res. A 2009, 89A, 124-137.
13. Hansson, A.; Hashom, N.; Falson, F.; Rousselle, P.; Jordan, O.; Borchard, G. In vitro evaluation of an RGD-functionalized chitosan derivative for enhanced cell adhesion. Carbohydr. Polym. 2012, 90, 1494-1500.
14. Liu, X.; Peng, W.; Wang, Y.; Zhu, M.; Sun, T.; Peng, Q.; Zeng, Y.; Feng, B.; Lu, X.; Weng, J.; et al. Synthesis of an RGD-grafted oxidized sodium alginate-N-succinyl chitosan hydrogel and an in vitro study of endothelial and osteogenic differentiation. J. Mater. Chem. B 2013, 1, 4484-4492.
15. Haubner, R.; Schmitt, W.; Hölzemann, G.; Goodman, S.L.; Jonczyk, A.; Kessler, H. Cyclic RGD peptides containing β-turn mimetics. J. Am. Chem. Soc. 1996, 118, 7881-7891.
16. Kessler, H. Conformation and biological activity of cyclic peptides. Angew. Chem. Int. Ed. 1982, 21, 512-523.
17. Zhu, S.; Zhang, J.; Janjana, J.; Vegesna, G.; Tiwari, A.; Luo, F.-T.; Wei, J.; Liu, H. Highly water-soluble, near-infrared emissive BODIPY polymeric dye bearing RGD peptide residues for cancer imaging. Anal. Chim. Acta 2013, 758, 138-144.
18. Meyer, A.; Auernheimer, J.; Modlinger, A.; Kessler, H. Targeting RGD recognizing integrins: Drug development, biomaterial research, tumor imaging and targeting. Curr. Pharm. Des. 2006, 12, 2723-2747.
19. Wang, F.; Li, Y.; Shen, Y.; Wang, A.; Wang, S.; Xie, T. The functions and applications of RGD in tumor therapy and tissue engineering. Int. J. Mol. Sci. 2013, 14, 13447-13462.
20. Danhier, F.; le Breton, A.; Preat, V. RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol. Pharm. 2012, 9, 2961-2973.
21. Hynes, R.O. A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 2002, 8, 918-921.
22. Aydin, D.; Louban, I.; Perschmann, N.; Blümmel, J.; Lohmüller, T.; Cavalcanti-Adam, E.A.; Haas, T.L.; Walczak, H.; Kessler, H.; Fiammengo, R.; et al. Polymeric substrates with tunable elasticity and nanoscopically controlled biomolecule presentation. Langmuir 2010, 26, 15472-15480.
23. Hoogenboom, R. Poly(2-oxazoline)s: A polymer class with numerous potential applications. Angew. Chem. Int. Ed. 2009, 48, 7978-7994.
24. Wiesbrock, F.; Hoogenboom, R.; Schubert, U.S. Microwave-assisted polymer synthesis: State-of-the-art and future perspectives. Macromol. Rapid Commun. 2004, 25, 1739-1764.
25. Wiesbrock, F.; Hoogenboom, R.; Leenen, M.A.M.; Meier, M.A.R.; Schubert, U.S. Investigation of the living cationic ring-opening polymerization of 2-methyl-, 2-ethyl-, 2-nonyl-, and 2-phenyl-2-oxazoline in a single-mode microwave reactor. Macromolecules 2005, 38, 5025-5034.
26. Wiesbrock, F.; Hoogenboom, R.; Leenen, M.A.M.; van Nispen, S.F.G.M.; van der Loop, M.; Abeln, C.H.; van den Berg, A.M.; Schubert, U.S. Microwave-assisted synthesis of a 42-membered library of diblock copoly(2-oxazoline)s and chain-extended homo poly(2-oxazoline)s and their thermal characterization. Macromolecules 2005, 38, 7957-7966.
27. Ebner, C.; Bodner, T.; Stelzer, F.; Wiesbrock, F. One decade of microwave-assisted polymerizations: Quo vadis? Macromol. Rapid Commun. 2011, 32, 254-288.
28. Bodner, C.; Ellmaier, L.; Schenk, V.; Albering, J.; Wiesbrock, F. Delocalized π-electrons in 2-oxazoline rings in negatively charged nitrogen atoms: Revealing the selectivity during the initiation of cationic ring-opening polymerizations. Polym. Int. 2011, 60, 1173-1179.
29. Rossegger, E.; Schenk, V.; Wiesbrock, F. Design strategies for functionalized poly(2-oxazoline)s and derived materials. Polymers 2013, 5, 956-1011.
30. Kelly, A.M.; Hecke, A.; Wirnsberger, B.; Wiesbrock, F. Synthesis of poly(2-oxazoline)-based hydrogels with tailor-made swelling degrees capable of stimuli-triggered compound release. Macromol. Rapid Commun. 2011, 32, 1815-1819.
31. Schenk, V.; Ellmaier, L.; Rossegger, E.; Edler, M.; Griesser, T.; Weidinger, G.; Wiesbrock, F. Water-developable poly(2-oxazoline)-based negative photoresist. Macromol. Rapid Commun. 2012, 33, 396-400.
32. Kempe, K.; Hoogenboom, R.; Schubert, U.S. A green approach for the synthesis and thiol-ene modification of alkene functionalized poly(2-oxazoline)s. Macromol. Rapid Commun. 2011, 32, 1484-1489.
33. Diehl, C.; Schlaad, H. Polyoxazoline-based crystalline microspheres for carbohydrate-protein recognition. Chem. Eur. J. 2009, 15, 11469-11472.
34. Witte, H; Seeliger, W. Cyclische imidsäureester aus nitrilen und aminoalkoholen. Liebigs Ann. Chem. 1974, 1974, 996-1009.
35. Beck, M.; Birnbrich, P.; Eicken, U.; Fischer, H.; Fristad, W.E.; Hase, B.; Krause, H.-J. Polyoxazoline auf fettchemischer Basis. Angew. Makromol. Chem. 1994, 223, 217-233.
36. Evers, B.M.; Townsend Jr., C.M.; Upp, J.R.; Allen, E.; Hurlbut, S.C.; Kim, S.W.; Rajaraman, S.; Singh, P.; Reubi, J.C.; Thompson J.C. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 1991, 101, 303-311.
37. Gloesenkamp, C.; Nitzsche, B.; Lim, A.R. Normant, E.; Vosburgh, E.; Schrader, M.; Ocker, M.; Scherübl, H.; Höpfner, M. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors. Int. J. Oncol. 2012, 40, 876-888.
38. Edgell, C.-J.S.; McDonald, C.C.; Graham, J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 1983, 80, 3734-3737.
39. Kade, M.J.; Burke, D.J.; Hawker, C.J. The power of thiol-ene chemistry. J. Polym. Sci. Part A Polym. Chem. 2010, 48, 743-750.
40. Höpfner, M.; Baradari, V.; Huether, A.; Schöfl, C.; Scherübl, H. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumors. Endocr. Relat. Cancer 2006, 13, 135-149.
41. Höpfner, M.; Schuppan, D.; Scherübl, H. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives. World J. Gastroenterol. 2008, 14, 2461-2473.
42. Fechner, H.; Wang, X.; Wang, H.; Jansen, A.; Pauschinger, M.; Scherübl, H.; Bergelson, J.M.; Schultheiss, H.-P.; Poller, W. Trans-complementation of vector replication vs. coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther. 2000, 7, 1954-1968.
43. Kelly, A.M.; Kaltenhauser, V.; Mühlbacher, I.; Rametsteiner, K.; Kren, H.; Slugovc, C.; Stelzer, F.; Wiesbrock, F. Poly(2-oxazoline)-derived contact biocides: Contributions to the understanding of antimicrobial activity. Macromol. Biosci. 2013, 13, 116-125.